Disclaimer:All content on this platform is sourced from the internet and is provided for informational purposes only. None of the content represents the views of this site, nor does it constitute investment advice. Please exercise caution when investing.
Gene-editing stocks rose on U.S. markets, with Beam Therapeutics up nearly 10%, CRISPR Therapeutics up over 7%, and Futa Pharmaceutical up over 4%.
Gene-editing stocks rose on U.S. markets, with Beam Therapeutics up nearly 10%, CRISPR Therapeutics up over 7%, and Futa Pharmaceutical up over 4%.
Disclaimer: This content reflects the author's personal views only and does not constitute investment advice. If you find any violations, please Click to Report
Recommended Reading


